首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Simultaneous Determination of udenafil and its Active Metabolite, DA-8164, in Free Fraction Human Plasma by LC-ESI/MS/MS
【24h】

Simultaneous Determination of udenafil and its Active Metabolite, DA-8164, in Free Fraction Human Plasma by LC-ESI/MS/MS

机译:通过LC-ESI / MS / MS同时测定udenafil及其活性代谢物,DA-8164,自由级分子血浆

获取原文

摘要

We established a new validated method for the simultaneous determination of udenafil, a phosphodiestaerase V inhibitor, and its active metabolite, DA-8164 in free fraction human plasma. The analytes were validated over the range from 1 ng/mL to 100 ng/mL. The precision and accuracy of QC samples were within +-15percent in terms of acceptance ariteria and were stable during the maximum period (24 hr at 4 deg C, 24 hr at room temperature, freeze and thaw at -70 deg C) of analysis. This sensitive and simple method appears to be useful for the pharmacokinetic analysis of the udenafil and DA-8164.
机译:我们建立了一种新的验证方法,用于同时测定Udenafil,磷代酶酶V抑制剂及其活性代谢物,DA-8164在自由级分子等离子体中。将分析物验证在1ng / ml至100ng / ml的范围内。 QC样品的精度和精度在接受结构方面+ -15%内+ -15%,在最大期间稳定(在4℃,24小时,室温下24小时,冷冻和冻解和-70℃)的分析。这种敏感和简单的方法似乎是对Udenafil和DA-8164的药代动力学分析有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号